GBM tumors with low HIF1α levels contain fewer bone marrow-derived cells and exhibit lower levels of angiogenesis and tumor growth, as compared to GBM tumors with high HIF1α levels [146]. The gene discussed is HIF1A; the disease is glioblastoma.